Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa Wang

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Medical Research and Opinion|August 2, 2016
Healthcare resource utilization of second-generation long-acting injectable antipsychotics in schizophrenia: risperidone versus paliperidone palmitateKruti Joshi, Xiaoyun Pan, Rosa Wang, et al.
Future Cardiology|September 26, 2022
Real-world treatment patterns and stroke risks among patients with atrial fibrillation in ChinaRosa Wang, Ning Ning, Shaoping Wang, et al.
Current Medical Research and Opinion|October 12, 2017
The burden of severe hypoglycemia in type 2 diabetesJieruo Liu, Rosa Wang, Michael L Ganz, et al.
Managed Care (Langhorne, Pa.)|December 18, 2015
Changes in Patterns of Utilization and Cost of Health Care Services Associated With Initiation of Asenapine for the Treatment of Schizophrenia in AdultsAbhishek Chitnis, Shawn X Sun, Shailja Dixit, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 19, 2025
The Economic Burden of Patients with Diabetic Peripheral Neuropathic Pain Based on a Real-World Study in ChinaRosa Wang, Dennis D Xuan, Jianwei Xuan, et al.
Journal of Medical Economics|June 30, 2015
Impact of initiation of asenapine on patterns of utilization and cost of healthcare resources associated with the treatment of bipolar I disorderAbhishek Chitnis, Rosa Wang, Shawn X Sun, et al.
Inflammatory Bowel Diseases|March 15, 2016
The Economic and Health-related Impact of Crohn's Disease in the United States: Evidence from a Nationally Representative SurveyMichael L Ganz, Rebecca Sugarman, Rosa Wang, et al.
Pharmacoeconomics|October 26, 2021
Is an Orphan Drug's Cost-Effectiveness Associated with US Health Plan Coverage Restrictiveness?James D Chambers, Nikoletta M Margaretos, Daniel E Enright, et al.
Current Medical Research and Opinion|October 12, 2017
The burden of severe hypoglycemia in type 1 diabetesJieruo Liu, Rosa Wang, Michael L Ganz, et al.
The American Journal of the Medical Sciences|January 23, 2019
Impact of Delayed Appropriate Antibiotic Therapy on Patient Outcomes by Antibiotic Resistance Status From Serious Gram-negative Bacterial InfectionsNicole Gidaya Bonine, Ariel Berger, Arman Altincatal, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Medical Research and Opinion|August 2, 2016
Healthcare resource utilization of second-generation long-acting injectable antipsychotics in schizophrenia: risperidone versus paliperidone palmitateKruti Joshi, Xiaoyun Pan, Rosa Wang, et al.
Future Cardiology|September 26, 2022
Real-world treatment patterns and stroke risks among patients with atrial fibrillation in ChinaRosa Wang, Ning Ning, Shaoping Wang, et al.
Current Medical Research and Opinion|October 12, 2017
The burden of severe hypoglycemia in type 2 diabetesJieruo Liu, Rosa Wang, Michael L Ganz, et al.
Managed Care (Langhorne, Pa.)|December 18, 2015
Changes in Patterns of Utilization and Cost of Health Care Services Associated With Initiation of Asenapine for the Treatment of Schizophrenia in AdultsAbhishek Chitnis, Shawn X Sun, Shailja Dixit, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 19, 2025
The Economic Burden of Patients with Diabetic Peripheral Neuropathic Pain Based on a Real-World Study in ChinaRosa Wang, Dennis D Xuan, Jianwei Xuan, et al.
Journal of Medical Economics|June 30, 2015
Impact of initiation of asenapine on patterns of utilization and cost of healthcare resources associated with the treatment of bipolar I disorderAbhishek Chitnis, Rosa Wang, Shawn X Sun, et al.
Inflammatory Bowel Diseases|March 15, 2016
The Economic and Health-related Impact of Crohn's Disease in the United States: Evidence from a Nationally Representative SurveyMichael L Ganz, Rebecca Sugarman, Rosa Wang, et al.
Pharmacoeconomics|October 26, 2021
Is an Orphan Drug's Cost-Effectiveness Associated with US Health Plan Coverage Restrictiveness?James D Chambers, Nikoletta M Margaretos, Daniel E Enright, et al.
Current Medical Research and Opinion|October 12, 2017
The burden of severe hypoglycemia in type 1 diabetesJieruo Liu, Rosa Wang, Michael L Ganz, et al.
The American Journal of the Medical Sciences|January 23, 2019
Impact of Delayed Appropriate Antibiotic Therapy on Patient Outcomes by Antibiotic Resistance Status From Serious Gram-negative Bacterial InfectionsNicole Gidaya Bonine, Ariel Berger, Arman Altincatal, et al.
Pageof 2